GPS1
Basic information
Region (hg38): 17:82050691-82057470
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 26 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 2 | 2 |
Variants in GPS1
This is a list of pathogenic ClinVar variants found in the GPS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-82050699-A-C | not specified | Uncertain significance (Nov 25, 2024) | ||
17-82050705-T-C | not specified | Uncertain significance (Dec 03, 2021) | ||
17-82050728-C-T | not specified | Likely benign (Jan 03, 2024) | ||
17-82051552-C-G | not specified | Uncertain significance (Aug 16, 2022) | ||
17-82051565-G-A | not specified | Uncertain significance (Apr 12, 2022) | ||
17-82051566-G-A | Benign (Dec 31, 2019) | |||
17-82051589-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
17-82051600-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
17-82051601-G-A | not specified | Uncertain significance (Mar 30, 2024) | ||
17-82051612-G-A | not specified | Uncertain significance (May 20, 2024) | ||
17-82051616-C-G | not specified | Uncertain significance (Oct 20, 2024) | ||
17-82051664-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
17-82051761-G-A | Likely benign (Oct 01, 2022) | |||
17-82052335-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
17-82052344-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
17-82052367-C-T | not specified | Uncertain significance (May 06, 2024) | ||
17-82052433-C-G | not specified | Uncertain significance (Apr 18, 2023) | ||
17-82053890-G-A | not specified | Uncertain significance (Jul 31, 2023) | ||
17-82053898-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
17-82053918-G-A | Likely benign (Jul 01, 2022) | |||
17-82053947-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
17-82053994-A-G | not specified | Uncertain significance (Dec 09, 2023) | ||
17-82054010-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
17-82054033-C-G | not specified | Uncertain significance (Aug 28, 2023) | ||
17-82054042-G-A | not specified | Uncertain significance (Jul 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPS1 | protein_coding | protein_coding | ENST00000392358 | 13 | 6780 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00181 | 125374 | 0 | 9 | 125383 | 0.0000359 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.86 | 235 | 330 | 0.712 | 0.0000211 | 3430 |
Missense in Polyphen | 40 | 96.996 | 0.41239 | 954 | ||
Synonymous | -3.30 | 195 | 145 | 1.35 | 0.0000101 | 1023 |
Loss of Function | 4.48 | 2 | 27.3 | 0.0734 | 0.00000133 | 311 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000105 | 0.0000995 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000481 | 0.0000462 |
European (Non-Finnish) | 0.0000460 | 0.0000442 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Essential component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN- dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. Suppresses G- protein- and mitogen-activated protein kinase-mediated signal transduction. {ECO:0000269|PubMed:11285227, ECO:0000269|PubMed:11337588, ECO:0000269|PubMed:12628923, ECO:0000269|PubMed:12732143, ECO:0000269|PubMed:9535219}.;
- Pathway
- DNA Repair;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Clathrin-mediated endocytosis;Neddylation;Cargo recognition for clathrin-mediated endocytosis;DNA Damage Recognition in GG-NER;Global Genome Nucleotide Excision Repair (GG-NER);Formation of TC-NER Pre-Incision Complex;Transcription-Coupled Nucleotide Excision Repair (TC-NER);Nucleotide Excision Repair
(Consensus)
Recessive Scores
- pRec
- 0.0897
Intolerance Scores
- loftool
- 0.0511
- rvis_EVS
- -0.89
- rvis_percentile_EVS
- 10.43
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.579
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.770
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gps1
- Phenotype
- embryo phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- inactivation of MAPK activity;protein deneddylation;nucleotide-excision repair, DNA damage recognition;transcription-coupled nucleotide-excision repair;JNK cascade;negative regulation of GTPase activity;post-translational protein modification
- Cellular component
- nucleoplasm;cytosol;COP9 signalosome
- Molecular function
- GTPase inhibitor activity;protein binding